<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Raymond James upgrades Healthpeak, downgrades Healthcare Realty to Underperform — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Raymond James upgrades Healthpeak, downgrades Healthcare Realty to Underperform</h2>
    <div class="badge">2025-09-15T12:56:55+00:00</div>
    <ul>
      <li>“Our HR downgrade is driven by 1) recent outperformance (18% vs.</li>
<li>“Our DOC upgrade is driven by 1) recent underperformance (15% vs.</li>
<li>main peer DOC, and 10% vs.</li>
<li>the healthcare REIT average the past three months) … 2) our expectation for limited downside to life science fundamentals going forward … 3) its attractive valuation (absolute and relative) and well-covered 6.7% dividend</li>
<li>the average of peers HR and ARE, and &gt;700 bp vs.</li>
<li>The firm set a $20 price target for Healthpeak, citing a mix of recent stock underperformance, attractive valuation, and a well-supported dividend.</li>
<li>Raymond James described HR’s new strategic plan as “a welcome and needed road map,” but added that “the stock has gotten a little ahead of itself.” Looking broadly, the analysts said, “seniors housing remains our preferr</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Raymond James upgrades Healthpeak, downgrades Healthcare Realty to Underperform\n• “Our HR downgrade is driven by 1) recent outperformance (18% vs.\n• “Our DOC upgrade is driven by 1) recent underperformance (15% vs.\n• main peer DOC, and 10% vs.\n• the healthcare REIT average the past three months) … 2) our expectation for limited downside to life science fundamentals going forward … 3) its attractive valuation (absolute and relative) and well-covered 6.7% dividend\n• the average of peers HR and ARE, and &gt;700 bp vs.\n• The firm set a $20 price target for Healthpeak, citing a mix of recent stock underperformance, attractive valuation, and a well-supported dividend.\n• Raymond James described HR’s new strategic plan as “a welcome and needed road map,” but added that “the stock has gotten a little ahead of itself.” Looking broadly, the analysts said, “seniors housing remains our preferr" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/raymond-james-upgrades-healthpeak-downgrades-125655474.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>